REFERENCE
1. Murai, M. and M. Oya, Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol, 2004. 14 (4): p. 229-33.
2. Petejova, N. and A. Martinek, Renal cell carcinoma: Review of etiology, pathophysiology and risk factors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016. 160 (2): p. 183-94.
3. Gray, R.E. and G.T. Harris, Renal Cell Carcinoma: Diagnosis and Management. Am Fam Physician, 2019. 99 (3): p. 179-184.
4. Cairns, P., Renal cell carcinoma. Cancer Biomark, 2010.9 (1-6): p. 461-73.
5. Warren, A.Y. and D. Harrison, WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol, 2018. 36 (12): p. 1913-1926.
6. Ljungberg, B., et al., EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol, 2015. 67 (5): p. 913-24.
7. Jin, P., et al., Challenges in Urology during the COVID-19 Pandemic. Urol Int, 2021. 105 (1-2): p. 3-16.
8. Ribal, M.J., et al., European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol, 2020. 78 (1): p. 21-28.
9. Méjean, A., et al., [Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19]. Prog Urol, 2020. 30 (5): p. 221-231.
10. Chang, Y.H., et al., Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma. Kaohsiung J Med Sci, 2011.27 (2): p. 59-63.
11. Chen, Y., et al., Integrin α7 is overexpressed and correlates with higher pathological grade, increased T stage, advanced TNM stage as well as worse survival in clear cell renal cell carcinoma patients: A retrospective study. J Clin Lab Anal, 2020. 34 (1): p. e23034.
12. Tachibana, I., et al., Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. J Urol, 2020. 204 (5): p. 926-933.
13. Lei, S., et al., Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine, 2020. 21 : p. 100331.
14. Tan, W.S., et al., Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes. Eur Urol Open Sci, 2021. 25 : p. 39-43.
15. Zequi, S.C. and D. Abreu, Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic. Int Braz J Urol, 2020. 46 (suppl.1): p. 69-78.
16. Lee, C.T., et al., Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol, 2002.7 (4): p. 135-40.
17. Srivastava, A., et al., Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urol Oncol, 2021. 39 (5): p. 247-257.
18. De Simone, B., et al., Emergency surgery during the COVID-19 pandemic: what you need to know for practice. Ann R Coll Surg Engl, 2020. 102 (5): p. 323-332.
19. Vigneswaran, Y., et al., What Is the Appropriate Use of Laparoscopy over Open Procedures in the Current COVID-19 Climate? J Gastrointest Surg, 2020. 24 (7): p. 1686-1691.
20. Louie, P.K., et al., Metastatic Renal Cell Carcinoma to the Spine and the Extremities: Evaluation, Diagnosis, and Treatment. JBJS Rev, 2019. 7 (9): p. e7.
21. Nguyen, M.M. and I.S. Gill, Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol, 2009.181 (3): p. 1020-7; discussion 1027.
22. Klatte, T., S.H. Rossi, and G.D. Stewart, Prognostic factors and prognostic models for renal cell carcinoma: a literature review.World J Urol, 2018. 36 (12): p. 1943-1952.
23. Uzosike, A.C., et al., Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry. J Urol, 2018. 199 (3): p. 641-648.
24. Daugherty, M., et al., The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.Urol Oncol, 2017. 35 (4): p. 153.e15-153.e20.
25. Kim, K.H., et al., The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin Oncol, 2012. 138 (9): p. 1561-7.